Evonik Industries is significantly expanding its global isophorone (IP) and isophorone diamine (IPD) capacities by funding an investment of more than €100M in Shanghai, China. The new production plants will be completed in the first quarter of 2014 and will increase the total capacities of IP and IPD significantly.
"We’re investing in China, because we are committed to the growth region Asia. As a world leader in isophorone-based products, we will continue to further consolidate and expand our position in this chemistry,” said Dr Ulrich Küsthardt, President of Evonik’s Coating & Additives Business Unit.
With the Group’s expansion strategy, it aims to support the growth ambitions of key customers in Asia and around the world.
